The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 582-588

  Inobe, Manabu ^a   Aoki, Naoko ^a   Linsley, Peter S ^b   Ledbetter, Jeffrey A ^b   Abe, Ryo ^c,d   Murakami, Masaaki ^a   Uede, Toshimitsu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b BRISTOL MYERS SQUIBB   (United States)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; FREUND ADJUVANT; IONOMYCIN; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; OVALBUMIN; PHORBOL 13 ACETATE 12 MYRISTATE; RIBONUCLEASE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD80; BASE SEQUENCE; CELLS, CULTURED; CHO CELLS; CRICETINAE; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0029949633     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
2. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
3. Rosenstreich, D. L., and S. B. Mizel. 1978. The participation of macrophages and macrophage cell lines in the activation of T lymphocytes by mitogens. Immunol. Rev. 40:102.
4. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
5. Van Seventer, G. A., Y. Shimizu, K. J. Morgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
6. Damle, N. K., K. Klussman, and A. Aruffo. 1992. Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides costimulatory signal for T-cell receptor-initiated activation of human T cells. J. Immunol. 148:665.
7. + T lymphocytes. Proc. Natl. Acad. Sci. USA 88:6403.
8. Liu, Y., B. Jones, A. Aruffo, K. M. Sullivan, P. S. Linsley, and C. A. Janeway Jr. 1992. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175:437.
9. Liu, Y., B. Jones, W. Brady, C. A. Janeway Jr., and P. S. Linsley. 1992. Costimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur. J. Immunol. 22:2855.
10. Bierer, B. E., A. Peterson, J. C. Gorga, S. H. Herrmann, and S. J. Burakoff. 1988. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J. Exp. Med. 168:1145.
11. Moingeon, P., H. C. Chang, B. P. Wallner, C. Stobbins, A. Z. Frey, and E. L. Reinherz. 1989. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 339:312.
12. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
13. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
14. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
15. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. J. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
16. Brunet, J. F., F. Denizot, M. F. Luciani, M. Roux-Dosseto, M. Suzan, M. G. Mattei, and P. Golstein. 1987. A new member of the immunoglobulin superfamily-CTLA-4. Nature 328:267.
17. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
18. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
19. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
20. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
21. Selvakumar, A., P. C. White, and B. Dupont. 1993. Genomic organization of the mouse B-lymphocyte activation antigen B7. Immunogenetics 38:292.
22. Inobe, M., P. S. Linsley, J. A. Ledbetter, Y. Nagai, M. Tamakoshi, and T. Uede. 1994. Identification of an alternatively spliced form of the murine homologue of B7. Biochem. Biophys. Res. Commun. 200:443.
23. Van de Winkel, J. G. J., and P. J. A. Capel. 1993. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 14: 215.
24. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577.
25. Delisser, H. M., P. J. Newman, and S. M. Albelda. 1993. Platelat endothelial cell adhesion molecule (CD31). Curr. Top. Microbiol. Immunol. 184:37.
26. Goridis, C., and J. F. Brunet. 1992. NCAM: structural diversity, function and regulation of expression. Semin. Cell Biol. 3:189.
27. Ogasawara, K., K. Iwabuchi, S. Kobayashi, N. Ishikawa, H. Ikeda, T. Natori, M Ogasawara, L. Geng, R. A. Good, and K. Onoe. 1987. An epitope on class II antigens that is maintained across species barriers and important in immunologic functions. Transplantation 43:427.
28. Sanchez-Madrid, F., P. Simon, S. Thompson, and T. A. Springer. 1983. Mapping of antigenic and functional epitopes on the a- and b-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and MAC-1. J. Exp. Med. 158:586.
29. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. M. Nadler, and L. H. Glimcher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266.
30. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. S. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
31. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
32. + T cells after CD28 receptor ligation. J. Immunol. 154:985.
33. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
34. Ogasawara, K., W. L. Maloy, B. Beverly, and R. H. Schwaltz. 1989. Functional analysis of the antigenic structure of a minor T cell determinant from pigeon cytochrome C: evidence against an α-helical conformation. J. Immunol. 142: 1448.
35. Hathcock, K. S., G. Laszlo, C. Pucillo, P. S. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
36. Yellin, M. J., J. Sinning, L. R. Covey, W. Sherman, J. J. Lee, N. E. Glickman, K. C. Sippel, J. Rogers, A. M. Cleary, M. Parker, L. Chess, and S. Lederman. 1994. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J. Immunol. 153:666.
37. Chen, C., A. Gault, L. Shen, and N. Nabavi. 1994. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 152:4929.
38. Damle, N. K., L. V. Doyle, L. S. Grosmire, and J. A. Ledbetter. 1988. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes. J. Immunol. 140:1753.
39. Ledbetter, J. A., J. B. Imboden, G. L. Schieven, L. S. Grosmaire, P. S. Rabinovitch, T. Lindsten, C. B. Thompson, and C. H. June. 1990. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 75:1531.
40. Guo, Y., Y. Wu, M. Zhao, X. P. Kong, and Y. Liu. 1995. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J. Exp. Med. 181:1345.
41. Fargeas, C. A., A. Truneh, M. Reddy, M. Hurle, R. Sweet, and R. P. Sekaly. 1995. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. J. Exp. Med. 182:667.
42. Peach, R. J., J. Bajorath, J. Naemura, G. Leytze, J. Greene, A. Aruffo, and P. S. Linsley. 1995. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 270:21181.